title: Monophasic demyelinating disease of the central nervous system associated with Hepatitis A infection.
authors.forename: L
authors.initials: L
authors.lastname: Quaranta
authors.forename: A P
authors.initials: AP
authors.lastname: Batocchi
authors.forename: M
authors.initials: M
authors.lastname: Sabatelli
authors.forename: V
authors.initials: V
authors.lastname: Nociti
authors.forename: T
authors.initials: T
authors.lastname: Tartaglione
authors.forename: F
authors.initials: F
authors.lastname: Cuonzo
authors.forename: P A
authors.initials: PA
authors.lastname: Tonali
mesh_terms: D000328:Adult; D000890:Anti-Infective Agents / Q000627:therapeutic use; D000956:Antigens, Viral / Q000276:immunology; D001323:Autoantibodies / Q000097:blood / Q000134:cerebrospinal fluid; D001921:Brain / Q000473:pathology / Q000503:physiopathology; D002490:Central Nervous System / Q000473:pathology* / Q000503:physiopathology*; D004673:Encephalomyelitis, Acute Disseminated / Q000175:diagnosis / Q000276:immunology* / Q000503:physiopathology*; D006506:Hepatitis A / Q000150:complications* / Q000276:immunology / Q000503:physiopathology; D030041:Hepatitis A virus / Q000276:immunology; D006801:Humans; D008279:Magnetic Resonance Imaging; D008297:Male; D008775:Methylprednisolone / Q000627:therapeutic use; D018716:Molecular Mimicry / Q000276:immunology; D013116:Spinal Cord / Q000473:pathology / Q000503:physiopathology; D016896:Treatment Outcome
chemical_list: D000890:Anti-Infective Agents; D000956:Antigens, Viral; D001323:Autoantibodies; D008775:Methylprednisolone